The CBD-based drug will now be prescribed through the NHS for seizures related to the condition.
Epidyolex can now be prescribed on the NHS for epilepsy-related tuberous sclerosis complex (TSC).
The approval for Epidyolex was based on the results of four randomised controlled Phase III trials
TSC can cause epilepsy in up to 85 percent of those with the condition and up to 60 percent do not respond to standard anti-seizure medicines.
A new report has revealed the ‘remarkable’ and ‘life-changing’ impact of medical cannabis on ten patients with severe epilepsy. The study, published by Drug Science, followed...
The European Medicines Agency has approved the first cannabis-based to treat two rare types of epilepsy which affect children.
